VI

NorthWest Healthcare Properties Real Estate Investment Trust

VITL-UN · TO · Real Estate / REIT - Healthcare Facilities

4.63CAD-0.10 (-2.11%)

Price History

Full chart

Market Stats

Previous Close4.73
Open4.72
Day Range4.60 – 4.74
52-Week Range4.60 – 5.81
Volume1.38M
Market Cap1.30B
P/E (TTM)0.00
Forward P/E11.64
EPS-0.33
Dividend Yield6.95%
Beta1.25
50-Day Avg5.36
200-Day Avg5.48

About

Vital Infrastructure Property Trust provides investors with access to a portfolio of high-quality international healthcare real estate infrastructure. As at March 31, 2026, the REIT held interests in a diversified portfolio of 134 income-producing properties totaling 13.1 million square feet of gross leasable area located throughout major markets in North America, Brazil, Europe and Australia. The REIT's portfolio of outpatient, inpatient, and other health research facilities is characterized by long-term indexed leases and stable occupancies. Vital Infrastructure leverages its global workforce in six countries to serve as a long-term real estate partner to leading healthcare operators. Vital Infrastructure Property Trust was established on January 1, 2010 and incorporated in 2010 in Ontario, Canada.

Company Details

  • SectorReal Estate
  • IndustryREIT - Healthcare Facilities
  • CEOMr. Zachary Brian Vaughan
  • Headquarters145 King Street West, Toronto, ON, Canada, M5H 1J8, Canada
  • Websitehttps://www.vitalreit.com

Leadership

  • Mr. Zachary Brian VaughanCEO & Non-Independent Trustee · b. 1978
  • Mr. Michael BradyPresident · b. 1968
  • Ms. Stephanie KaramarkovicChief Financial Officer
  • Ms. Tracey WhittallChief Operating Officer
  • Mr. Dave CasimiroExecutive Vice President
  • Mr. Steven HongVice President of Investor Relations
  • Ms. Vanessa FlaxRegional General Counsel and Company Secretary · b. 1972
  • Mr. Gerson AmadoManaging Director of Brazil
  • Mr. Richard RoosManaging Director of Australia · b. 1966
  • Mr. Chris AdamsCo- Head Australia & New Zealand · b. 1970

Financials

Income Statement

Currency: CAD2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue64.97M118.15M134.46M150.11M150.43M198.96M277.35M313.97M349.59M366.06M373.82M374.61M448.83M508.00M462.40M386.02M
Growth (%)-+81.85%+13.80%+11.64%+0.21%+32.26%+39.40%+13.20%+11.35%+4.71%+2.12%+0.21%+19.81%+13.18%-8.98%-16.52%
Cost of Revenue18.77M53.68M60.83M68.59M69.64M53.00M72.65M74.18M79.59M75.92M76.36M68.55M100.48M121.37M113.00M114.89M
Gross Profit46.20M64.48M73.63M81.52M80.79M145.96M204.70M239.78M270.00M290.13M297.46M306.06M348.35M386.62M349.41M271.13M
Gross Margin71.11%54.57%54.76%54.31%53.71%73.36%73.81%76.37%77.23%79.26%79.57%81.70%77.61%76.11%75.56%70.24%
Operating Expense30.84M3.22M15.22M-3.68M3.08M29.29M61.38M25.70M-11.84M145.48M-94.89M-50.95M-10.07M42.21M43.02M56.61M
Operating Income15.36M61.25M58.41M85.20M77.70M116.67M143.32M214.08M281.84M144.65M392.35M357.01M358.42M344.41M306.38M214.52M
Operating Margin23.64%51.84%43.44%56.76%51.66%58.64%51.68%68.19%80.62%39.52%104.96%95.30%79.86%67.80%66.26%55.57%
EBITDA35.63M61.25M120.54M96.08M77.70M116.94M144.07M215.49M257.57M146.63M393.93M358.40M359.82M-263.91M-168.34M173.39M
EBITDA Margin54.83%51.84%89.65%64.01%51.66%58.78%51.95%68.64%73.68%40.06%105.38%95.67%80.17%-51.95%-36.41%44.92%
Net Income1.05M78.34M92.49M36.52M-22.20M116.85M56.96M67.39M65.72M73.25M314.36M611.84M125.63M-347.69M-299.76M-52.85M
Net Income Margin1.62%66.31%68.79%24.33%-14.75%58.73%20.54%21.46%18.80%20.01%84.09%163.33%27.99%-68.44%-64.83%-13.69%
R&D------0.630.720.570.470.899.44M3.43M0--
R&D as % of Total Revenue------0.00%0.00%0.00%0.00%0.00%2.52%0.76%0.00%--
Interest Expense13.79M23.43M28.42M31.25M31.60M78.00M85.90M105.44M143.40M130.81M103.33M102.17M163.88M233.85M197.70M143.86M
Interest Expense % of Total Revenue21.22%19.83%21.14%20.82%21.01%39.20%30.97%33.58%41.02%35.73%27.64%27.27%36.51%46.03%42.76%37.27%

Balance Sheet

Currency: CAD2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets724.73M1.01B1.28B1.31B1.24B2.70B3.33B4.68B5.07B5.54B5.85B7.06B8.51B7.63B6.05B3.45B
Total Liabilities395.03M615.46M781.70M806.35M786.13M1.86B2.14B3.03B3.39B3.46B3.31B3.54B4.77B4.54B3.47B1.95B
Total Equity329.70M396.26M499.78M508.64M458.51M515.48M704.28M947.67M947.72M1.32B1.64B2.39B2.46B1.99B1.56B1.51B
Cash46.31M3.72M4.19M1.91M2.51M14.84M19.95M71.70M45.81M192.15M144.11M62.70M87.99M72.03M51.25M94.08M
Total Debt372.05M501.76M661.22M698.63M688.64M1.42B1.70B2.42B2.81B2.73B2.79B2.94B3.68B3.92B3.01B1.38B
Net Debt325.74M498.04M657.03M696.72M686.13M1.41B1.68B2.35B2.77B2.54B2.64B2.88B3.59B3.85B2.96B1.29B

Cash Flow

Currency: CAD2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow18.55M32.26M38.51M38.63M41.68M46.59M102.08M90.84M93.31M115.82M188.77M124.97M224.18M104.77M86.64M162.08M
Investing Cash Flow-169.17M-233.60M-150.30M-39.15M-5.13M-64.38M-452.18M-773.31M-325.18M-341.49M-628.53M-914.83M-1.36B194.27M540.08M216.39M
Financing Cash Flow196.93M158.74M112.26M-1.75M-35.94M13.90M346.27M739.65M205.83M383.64M397.61M711.19M1.18B-318.50M-650.57M-348.43M
Capital Expenditure0230.75M000230.00K765.00K1.75M413.00K377.00K234.00K483.00K615.00K98.00K882.00K1.91M
Free Cash Flow18.55M-198.49M38.51M38.63M41.68M46.36M101.31M89.09M92.90M115.44M188.53M124.48M223.56M104.67M85.76M160.17M
Dividends Paid--26.50M28.46M34.36M58.28M59.98M77.50M88.24M100.10M133.45M137.72M156.11M148.75M78.43M77.02M
FCF to OCF100.00%-615.25%100.00%100.00%100.00%99.51%99.25%98.08%99.56%99.67%99.88%99.61%99.73%99.91%98.98%98.82%
Dividend Paid to FCF--68.82%73.68%82.44%125.72%59.21%86.98%94.98%86.71%70.78%110.63%69.83%142.12%91.45%48.09%

Earnings

Report DateNov 11, 2026
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap1.30B
Enterprise Value2.51B
Trailing P/E0.00
Forward P/E11.64
Price / Sales3.31
Price / Book0.85
EPS-0.33
Book Value6.14
Revenue (TTM)391.14M
Gross Profit (TTM)294.08M
EBITDA239.95M
Profit Margin-20.83%
Operating Margin59.38%
Return on Equity0.03%
Return on Assets3.25%
Shares Outstanding250.02M
Shares Float219.48M
Beta1.25
Dividend Yield6.95%
Dividend Rate0.36
Payout Ratio179.60%

Dividends

202610×
0.03Oct 30, 20260.03Sep 29, 20260.03Aug 31, 20260.03Jul 31, 20260.03Jun 30, 20260.03May 29, 20260.03Apr 30, 20260.03Mar 31, 20260.03Feb 27, 20260.03Jan 30, 2026
202512×
0.03Dec 31, 20250.03Nov 28, 20250.03Oct 31, 20250.03Sep 29, 20250.03Aug 29, 20250.03Jul 31, 20250.03Jun 30, 20250.03May 30, 20250.03Apr 30, 20250.03Mar 31, 20250.03Feb 28, 20250.03Jan 31, 2025
20242×
0.03Dec 31, 20240.03Nov 29, 2024